Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 7;32(8):1192-1199.e11.
doi: 10.1016/j.stem.2025.07.003. Epub 2025 Jul 30.

Chemical reprogramming of human blood cells to pluripotent stem cells

Affiliations

Chemical reprogramming of human blood cells to pluripotent stem cells

Fangqi Peng et al. Cell Stem Cell. .

Abstract

Chemical reprogramming offers a fundamentally innovative approach for generating human chemically induced pluripotent stem (hCiPS) cells using small molecules. Our recent studies showed that this approach was highly efficient in reprogramming human fibroblasts to hCiPS cells. However, generating hCiPS cells from human blood cells, which are the most accessible and convenient source for reprogramming, remains a challenge. In this study, we established a robust method that successfully generated hCiPS cells from both cord blood and adult peripheral blood cells. This method achieved efficient reprogramming with both fresh and cryopreserved blood cells across different donors. Notably, this method also efficiently generated an average of over 100 hCiPS colonies from just a single drop of fingerstick blood. These results highlight the advantages of chemical reprogramming for generating hCiPS cells from a blood source and represent a next-generation platform for efficient, scalable, and convenient stem cell production with broad applications in regenerative medicine.

Keywords: adult peripheral blood; chemical reprogramming; hCiPS cells; human cord blood; pluripotency; small molecules.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors have filed a patent for the small-molecule combinations reported in this paper. H.D. is an advisory board member of Cell Stem Cell.

MeSH terms

LinkOut - more resources